BRENNAN KEVIN M. (SVP, FINANCE AND ACCOUNTING) sold 36.1% of their position (1.80K shares) of XILIO THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/3/2025ACC: 0001415889-25-000404
Officer· SVP, FINANCE AND ACCOUNTING
Since Mar 2023
+58.20K
Net shares
Net buyer
$1.8K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
65K acquired · 6.80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
New position
1/1/2025
0.00→5K
Common stock
Direct
Shares
−1.80K
Price / share
$0.98
Trade value
$1.77K
% of position
36.1%
1/2/2025
5K→3.20K
Total
Net shares
+3.20K
Net value
-$1.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2025 | M · Option Exercise | +5K | — | — | New position | 0.00 | 5K |
| Common stock Direct | 1/2/2025 | S · Sale | −1.80K | $0.98 | $1.77K | 36.1% | 5K | 3.20K |
| Total | +3.20K | -$1.77K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
15K
Exercisable
—
1/1/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
60K shares
Shares
+60K
Strike price
0.955
Held after
60K
Exercisable
—
1/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5K shares | 1/1/2025 | M · Option Exercise | −5K | — | 15K | |
| Stock Option (right to buy) Direct | Common Stock60K shares | 1/1/2025 | A · Award | +60K | 0.955 | — | 60K |